Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monali Manohar

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2015
Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6Siddheshvar Bhela, Christine Kempsell, Monali Manohar, et al.
The Journal of Allergy and Clinical Immunology|February 12, 2024
Untargeted metabolomic profiling in children identifies novel pathways in asthma and atopyStéphanie Lejeune, Abhinav Kaushik, Ella S Parsons, et al.
Scientific Data|December 1, 2022
Mass cytometry analysis of blood from peanut-sensitized tolerant and clinically allergic infantsAmanda R Tursi, Nicholas K Saba, Diane Dunham, et al.
Nature Communications|February 29, 2020
Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early lifeMelanie R Neeland, Sandra Andorf, Monali Manohar, et al.
Clinical Immunology (Orlando, Fla.)|August 14, 2020
Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapyWeiqi Wang, Shu-Chen Lyu, Xuhuai Ji, et al.
Immunology|January 30, 2026
Genetic Determinants of Peanut-Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP StudyKanika Kanchan, Karen Cerosaletti, James A Perry, et al.
Lancet (London, England)|September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyR Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
Frontiers in Immunology|December 5, 2022
HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic successKanika Kanchan, Gautam Shankar, Michelle F Huffaker, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2015
Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6Siddheshvar Bhela, Christine Kempsell, Monali Manohar, et al.
The Journal of Allergy and Clinical Immunology|February 12, 2024
Untargeted metabolomic profiling in children identifies novel pathways in asthma and atopyStéphanie Lejeune, Abhinav Kaushik, Ella S Parsons, et al.
Scientific Data|December 1, 2022
Mass cytometry analysis of blood from peanut-sensitized tolerant and clinically allergic infantsAmanda R Tursi, Nicholas K Saba, Diane Dunham, et al.
Nature Communications|February 29, 2020
Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early lifeMelanie R Neeland, Sandra Andorf, Monali Manohar, et al.
Clinical Immunology (Orlando, Fla.)|August 14, 2020
Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapyWeiqi Wang, Shu-Chen Lyu, Xuhuai Ji, et al.
Immunology|January 30, 2026
Genetic Determinants of Peanut-Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP StudyKanika Kanchan, Karen Cerosaletti, James A Perry, et al.
Lancet (London, England)|September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyR Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
Frontiers in Immunology|December 5, 2022
HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic successKanika Kanchan, Gautam Shankar, Michelle F Huffaker, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Pageof 4